239 related articles for article (PubMed ID: 12457396)
41. A variable number of tandem repeats in the 3'-untranslated region of the dopamine transporter modulates striatal function during working memory updating across the adult age span.
Sambataro F; Podell JE; Murty VP; Das S; Kolachana B; Goldberg TE; Weinberger DR; Mattay VS
Eur J Neurosci; 2015 Aug; 42(3):1912-8. PubMed ID: 25997640
[TBL] [Abstract][Full Text] [Related]
42. Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD.
Oh KS; Shin DW; Oh GT; Noh KS
Yonsei Med J; 2003 Oct; 44(5):787-92. PubMed ID: 14584093
[TBL] [Abstract][Full Text] [Related]
43. DAT1 3'-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder.
Das M; Mukhopadhyay K
Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):826-9. PubMed ID: 17440935
[TBL] [Abstract][Full Text] [Related]
44. Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.
Brookes KJ; Neale BM; Sugden K; Khan N; Asherson P; D'Souza UM
Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1070-8. PubMed ID: 17579365
[TBL] [Abstract][Full Text] [Related]
45. 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression.
Zamorano R; Suchindran S; Gainer JV
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F456-64. PubMed ID: 16144969
[TBL] [Abstract][Full Text] [Related]
46. Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.
Hill M; Anney RJ; Gill M; Hawi Z
Pharmacogenomics J; 2010 Oct; 10(5):442-7. PubMed ID: 20029387
[TBL] [Abstract][Full Text] [Related]
47. The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample.
Chen CK; Chen SL; Mill J; Huang YS; Lin SK; Curran S; Purcell S; Sham P; Asherson P
Mol Psychiatry; 2003 Apr; 8(4):393-6. PubMed ID: 12740596
[TBL] [Abstract][Full Text] [Related]
48. Association between the dopamine transporter gene and posttraumatic stress disorder.
Segman RH; Cooper-Kazaz R; Macciardi F; Goltser T; Halfon Y; Dobroborski T; Shalev AY
Mol Psychiatry; 2002; 7(8):903-7. PubMed ID: 12232785
[TBL] [Abstract][Full Text] [Related]
49. Dopamine transporter gene associated with diminished subjective response to amphetamine.
Lott DC; Kim SJ; Cook EH; de Wit H
Neuropsychopharmacology; 2005 Mar; 30(3):602-9. PubMed ID: 15602501
[TBL] [Abstract][Full Text] [Related]
50. Genetic polymorphisms of serotonin and dopamine transporters in mental disorders.
Ueno S
J Med Invest; 2003 Feb; 50(1-2):25-31. PubMed ID: 12630565
[TBL] [Abstract][Full Text] [Related]
51. Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population.
Georgieva L; Dimitrova A; Nikolov I; Koleva S; Tsvetkova R; Owen MJ; Toncheva D; Kirov G
Acta Psychiatr Scand; 2002 May; 105(5):396-9. PubMed ID: 11942948
[TBL] [Abstract][Full Text] [Related]
52. Amplification of DAT1 (human dopamine transporter gene) 3' variable region in the Japanese population.
Nakatome M; Honda K; Islam MN; Terada M; Yamazaki M; Kuroki H; Ogura Y; Bai H; Wakasugi C
Hum Hered; 1995; 45(5):262-5. PubMed ID: 7590757
[TBL] [Abstract][Full Text] [Related]
53. [VNTR and transcription regulator].
Koyama K; Nakamura Y
Tanpakushitsu Kakusan Koso; 1997 Dec; 42(17 Suppl):2798-805. PubMed ID: 9455196
[No Abstract] [Full Text] [Related]
54. Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.
Kelada SN; Costa-Mallen P; Checkoway H; Carlson CS; Weller TS; Swanson PD; Franklin GM; Longstreth WT; Afsharinejad Z; Costa LG
Pharmacogenet Genomics; 2005 Sep; 15(9):659-68. PubMed ID: 16041244
[TBL] [Abstract][Full Text] [Related]
55. ADHD and DAT1: further evidence of paternal over-transmission of risk alleles and haplotype.
Hawi Z; Kent L; Hill M; Anney RJ; Brookes KJ; Barry E; Franke B; Banaschewski T; Buitelaar J; Ebstein R; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Sonuga-Barke E; Steinhausen HC; Faraone SV; Asherson P; Gill M
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):97-102. PubMed ID: 19388000
[TBL] [Abstract][Full Text] [Related]
56. Dopamine transporter (DAT1) VNTR polymorphism in 12 Indian populations.
Bhaskar LV; Thangaraj K; Mulligan CJ; Wasnik S; Nandan A; Sharma VK; Sharma V; Reddy AG; Singh L; Rao VR
Neurol Sci; 2009 Dec; 30(6):487-93. PubMed ID: 19779799
[TBL] [Abstract][Full Text] [Related]
57. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism.
Ueno S; Nakamura M; Mikami M; Kondoh K; Ishiguro H; Arinami T; Komiyama T; Mitsushio H; Sano A; Tanabe H
Mol Psychiatry; 1999 Nov; 4(6):552-7. PubMed ID: 10578237
[TBL] [Abstract][Full Text] [Related]
58. Dopamine transporter (DAT1) VNTR polymorphism and alcoholism in two culturally different populations of south India.
Bhaskar LV; Thangaraj K; Wasnik S; Singh L; Raghavendra Rao V
Am J Addict; 2012; 21(4):343-7. PubMed ID: 22691013
[TBL] [Abstract][Full Text] [Related]
59. Distribution of the 3' VNTR polymorphism in the human dopamine transporter gene in world populations.
Mitchell RJ; Howlett S; Earl L; White NG; McComb J; Schanfield MS; Briceno I; Papiha SS; Osipova L; Livshits G; Leonard WR; Crawford MH
Hum Biol; 2000 Apr; 72(2):295-304. PubMed ID: 10803661
[TBL] [Abstract][Full Text] [Related]
60. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1).
Grünhage F; Schulze TG; Müller DJ; Lanczik M; Franzek E; Albus M; Borrmann-Hassenbach M; Knapp M; Cichon S; Maier W; Rietschel M; Propping P; Nöthen MM
Mol Psychiatry; 2000 May; 5(3):275-82. PubMed ID: 10889530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
